ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,205Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1269

$728K Total Retail Price of All Prescriptions

Rank: 52 out of 1269

786 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 786 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 786 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,414 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 479 411 1 1
SIMVASTATIN 476 405 2 3
LEVOTHYROXINE SODIUM 387 284 3 4
LOVASTATIN 353 304 4 30
AMLODIPINE BESYLATE 303 282 5 2
METOPROLOL TARTRATE 302 262 6 6
FUROSEMIDE 263 223 7 5
OMEPRAZOLE 249 206 8 8
SERTRALINE HCL 221 197 9 23
METFORMIN HCL 221 185 9 9
CITALOPRAM HBR 195 165 11 21
PRAVASTATIN SODIUM 183 141 12 11
AZITHROMYCIN 179 147 13 42
BISOPROLOL-HYDROCHLOROTHIAZIDE 178 171 14 196
METOPROLOL SUCCINATE 175 149 15 13
WARFARIN SODIUM 171 159 16 12
ZOLPIDEM TARTRATE 165 135 17 19
LOSARTAN POTASSIUM 165 141 17 15
ATENOLOL 157 139 19 14
ATORVASTATIN CALCIUM 156 143 20 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 126 21 33
CLOPIDOGREL 146 130 22 32
TRAMADOL HCL 134 122 23 16
HYDROCHLOROTHIAZIDE 107 79 24 10
PLAVIX 102 94 25 47
TAMSULOSIN HCL 100 100 26 31
DONEPEZIL HCL 95 95 27 22
CRESTOR 86 86 28 25
GLYBURIDE 85 73 R 29 94
ALLOPURINOL 84 78 30 49
HYDROCODONE-ACETAMINOPHEN 84 71 S3 30 20
GLIMEPIRIDE 83 71 32 57
CEPHALEXIN 78 68 33 113
PANTOPRAZOLE SODIUM 77 71 34 18
GLYBURIDE-METFORMIN HCL 76 68 R 35 172
CIPROFLOXACIN HCL 76 70 35 66
CARVEDILOL 76 76 35 29
NEXIUM 75 50 38 41
OXYCODONE-ACETAMINOPHEN 74 69 S2 39 44
ACETAMINOPHEN-CODEINE 74 73 S3 39 98
RANITIDINE HCL 73 57 41 27
LACTULOSE 71 32 42 67
ADVAIR DISKUS 70 54 43 46
GABAPENTIN 70 52 43 17
LOSARTAN-HYDROCHLOROTHIAZIDE 69 69 45 59
TRIAMTERENE-HCTZ 67 51 46 69
SPIRIVA 66 58 47 64
IBUPROFEN 62 35 48 73
AMLODIPINE BESYLATE-BENAZEPRIL 62 54 48 81
OXYBUTYNIN CHLORIDE ER 61 49 50 130
TRAZODONE HCL 61 56 50 36
ISOSORBIDE MONONITRATE ER 60 58 52 63
DIGOXIN 58 41 53 62
ZETIA 58 51 53 99
FLUOXETINE HCL 56 29 55 83
VYTORIN 55 35 56 168
PAROXETINE HCL 54 50 57 71
SYNTHROID 52 35 58 72
ALENDRONATE SODIUM 51 39 59 28
TRIAMCINOLONE ACETONIDE 51 40 59 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.